Clinical Trials Logo

Brain Neoplasms clinical trials

View clinical trials related to Brain Neoplasms.

Filter by:

NCT ID: NCT02810899 Completed - Brain Neoplasms Clinical Trials

Dexmedetomidine and Intelligence Development in Pediatric Patients Undergoing Craniotomy

Start date: September 2015
Phase: Phase 4
Study type: Interventional

The purpose of this randomized, double-blind and placebo-controlled pilot study is to investigate whether dexmedetomidine when used as an adjuvant to general anesthesia can decrease the harmful effects of anesthesia and surgery on intelligence development in pediatric patients undergoing craniotomy.

NCT ID: NCT02808416 Completed - Brain Cancer Clinical Trials

Personalized Cellular Vaccine for Brain Metastases (PERCELLVAC3)

PerCellVac3
Start date: March 1, 2016
Phase: Phase 1
Study type: Interventional

Cancer patients with brain metastases (BM) have poor prognosis. Current treatments produce limited efficacy. Recent advance in cancer immunotherapy has provided important new means to treat cancer patients at advanced stages. This study is designed to perform a clinical trial to treat advanced caner patients with brain metastases with personalized dendritic cell-based cellular vaccines. The patients will receive vaccines consisting of mRNA tumor antigen pulsed DCs. Immune response to the immunized tumor antigens will be monitored. Safety and efficacy will be observed in this study.

NCT ID: NCT02798406 Completed - Glioblastoma Clinical Trials

Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects

CAPTIVE
Start date: October 6, 2016
Phase: Phase 2
Study type: Interventional

Glioblastoma (GBM) and gliosarcoma (GS) are the most common and aggressive forms of malignant brain tumor in adults and can be resistant to conventional therapies. The purpose of this Phase II study is to evaluate how well a recurrent glioblastoma or gliosarcoma tumor responds to one injection of DNX-2401, a genetically modified oncolytic adenovirus, when delivered directly into the tumor followed by the administration of intravenous pembrolizumab (an immune checkpoint inhibitor) given every 3 weeks for up to 2 years or until disease progression. Funding Source-FDA OOPD

NCT ID: NCT02798029 Completed - Clinical trials for Metastatic Malignant Neoplasm in the Brain

Frameless Fractionated Stereotactic Radiation in Treating Patients With Brain Metastases

Start date: August 8, 2016
Phase: Phase 2
Study type: Interventional

This phase II trial studies the safety and efficacy of frameless fractionated stereotactic radiation therapy for brain metastases. Frameless fractionated stereotactic radiosurgery is a specialized radiation therapy that delivers 3 to 5, high dose fractions of radiation directly to the brain lesions while sparing normal tissues.

NCT ID: NCT02792608 Completed - Depressive Symptoms Clinical Trials

Mindfulness-Based Therapy for Brain Tumour Survivors

Start date: August 2016
Phase: N/A
Study type: Interventional

Brain Tumour (BT) survivors struggle with disabling physical, emotional, cognitive and psychosocial sequelae. Unfortunately, to-date there has been very limited research into rehabilitative interventions for this population. With 55,000 BT survivors in Canada alone1, access to effective, evidence-based rehabilitative treatment that would improve BT survivors' quality of life (QOL) and capacity to cope is a necessity. Mindfulness-Based Therapy's (MBTs) are emerging as a potential treatment to address this need. MBTs are group-based psychological treatments for coping with illness or disability, with the goal of improving psychological wellbeing. Recent studies have begun to suggest a role for MBTs in addressing symptom burden and QOL in the acquired brain injury (ABI) population, a heterogeneous population that includes survivors of stroke and traumatic brain injury, as well as BT survivors. High quality research including within-subject controlled trials, are needed to demonstrate whether MBTs can provide efficacious, accessible and cost-effective treatment to improve the lives of BT survivors.

NCT ID: NCT02791360 Completed - Brain Neoplasms Clinical Trials

Evaluation of Anatomy, Clinical and Neuropsychological Long-term Sequelae of Patients Treated With Radiation Therapy for Brain Tumor

TCSEQ
Start date: January 2016
Phase: N/A
Study type: Interventional

Through this study, the investigators believe to describe more accurately the damage caused by brain radiation therapy in the long term.

NCT ID: NCT02768389 Completed - Glioblastoma Clinical Trials

Feasibility Trial of the Modified Atkins Diet and Bevacizumab for Recurrent Glioblastoma

Start date: September 6, 2016
Phase: Early Phase 1
Study type: Interventional

Patients may participate in this research study if they have glioblastoma. (a brain tumor) that has come back after being treated. Standard treatment for this cancer is a chemotherapy drug called bevacizumab. This research study involves bevacizumab in combination with a special diet called the Modified Atkins Diet (MAD). The purpose of this study is to research if patients can stay on the MAD when it is added to the standard bevacizumab treatment.

NCT ID: NCT02757690 Completed - Clinical trials for Benign Neoplasm of Tail of Pancreas

Validation of 3 Dimensional Laparoscopic System in Disral Pancreatectomy and Splenectomy

Start date: January 2015
Phase: Phase 4
Study type: Interventional

Traditionally, laparoscopy has been based on 2-dimensional (2D) imaging, which has represented a considerable challenge for those approaching this technique. Thus, 3-dimensional (3D) visualization technology for laparoscopy has been proposed, since the early 1990s, as a way to facilitate laparoscopic performance. However, early 3D laparoscopic technology was limited in terms of image quality, so that its use had not been implemented. More recently, industry has developed novel 3D systems where the imaging is similar to stereoscopic vision, in which the depth perception is achieved by different unique images received by each eye. Thus, more recent studies have suggested a possible advantage provided by these new 3D systems during laparoscopic performance. However, comparative assessments of new generation 3D vs 2D laparoscopy remain limited, especially in the hepatobiliary and pancreatic field. To assess the benefits and harms of use of three dimensional systems versus two dimensional systems during laparoscopic distal pancreatectomy.

NCT ID: NCT02755142 Completed - Brain Neoplasm Clinical Trials

Clinical Study on 5-aminolevulinic Acid Hydrochloride (5-ALA) for Fluorescence-guided Resection of Malignant Gliomas

Start date: February 2000
Phase: Phase 1/Phase 2
Study type: Interventional

This study is planned to detect a dose-efficacy relationship between the chosen dose levels of MC506/1 and the extent and quality of fluorescence in the tumour core in patients with newly diagnosed malignant glioma.

NCT ID: NCT02754908 Completed - Child Clinical Trials

Effectiveness of Musical Training in Children Surviving Brain Tumours

Start date: January 2016
Phase: N/A
Study type: Interventional

This study aims to examine the effects of musical training on improving the neurocognitive function and psychological well-being of children surviving brain tumours. Half of the participants will receive weekly 45-minute lessons on musical training for one year (52 weeks) while the other half are the placebo controls.